Adenocarcinoma of the Rectum
Showing 1 - 25 of 2,842
Rectal Cancer Trial in Detroit (Standard of care chemo with the change for avoidance of extensive surgery)
Recruiting
- Rectal Cancer
- Standard of care chemotherapy with the change for avoidance of extensive surgery
-
Detroit, MichiganAscension St. John Hospital
Jan 30, 2023
Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Kaliningrad (Right hemicolectomy, Left hemicolectomy, Sigmoid colon
Recruiting
- Colorectal Cancer
- +5 more
- Right hemicolectomy
- +6 more
-
Kaliningrad, Kaliningrad Region, Russian FederationBaltic Federal University
Sep 15, 2023
Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)
Terminated
- Mucinous Adenocarcinoma of the Colon
- Mucinous Adenocarcinoma of the Rectum
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Sep 26, 2022
Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)
Terminated
- Non-Metastatic Adenocarcinoma of the Rectum
- Radiation Therapy
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021
Mt-sDNA asSurveillance Procedure in Colorectal Cancer Survivors
Not yet recruiting
- Adenocarcinoma of the Colon
- +4 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 30, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Rectal Adenocarcinoma, Rectum Tumor, Rectum Carcinoma Trial in Helsinki, Tampere, Turku (Oral Antibiotics, Placebo, Mechanical
Active, not recruiting
- Rectal Adenocarcinoma
- +7 more
- Oral Antibiotics
- +2 more
-
Helsinki, Finland
- +2 more
Nov 16, 2022
Adenocarcinoma of the Pancreas, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Lyon (Pembrolizumab,
Active, not recruiting
- Adenocarcinoma of the Pancreas
- +2 more
-
Lyon, FranceCentre Léon Bérard
Mar 17, 2022
Rectum Adenocarcinoma Trial in Paris, Saint-Cloud (Biopsy)
Recruiting
- Rectum Adenocarcinoma
- Biopsy
-
Paris, Ile De France, France
- +2 more
Mar 30, 2022
Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,
Recruiting
- Adenocarcinoma of the Rectum
- +4 more
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Cancer of Rectum, Cancer of the Rectum, Tumor, Rectum Trial in Saint Louis (Radiation, Oxaliplatin, Leucovorin)
Completed
- Cancer of Rectum
- +6 more
- Radiation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 10, 2021
Biopsy After Radioembolization to Identify Changes in Tumor
Recruiting
- Colon Cancer Liver Metastasis
- +5 more
- Y90 TARE
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 30, 2022
Colorectal Tumors Malignant Trial in Philadelphia (Axitinib 5 MG, Hydroxychloroquine Pill, trans arterial chemoembolization)
Recruiting
- Colorectal Neoplasms Malignant
- Axitinib 5 MG
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center
May 2, 2022
Neoadjuvent Radiotherapy in Locally Advanced Cancer Rectum
Not yet recruiting
- Rectal Adenocarcinoma
- Neoadjuvent radiotherapy either short or long course chemoradiation in treatment of locally advanced cancer rectum
-
Assiut, EgyptSouth Egypt cancer Institute
Mar 23, 2021
Rectal Cancer, Adenocarcinoma, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Madrid (neoadjuvant treatment)
Completed
- Rectal Cancer, Adenocarcinoma
- +4 more
- neoadjuvant treatment
-
Madrid, SpainHospital La Princesa
Aug 8, 2022
Prostatic Adenocarcinoma Trial in France (Moderate hypofractionated radiotherapy, Stereotactic radiotherapy)
Completed
- Prostatic Adenocarcinoma
- Moderate hypofractionated radiotherapy
- Stereotactic radiotherapy
-
Albi, France
- +6 more
Mar 2, 2022
Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma Trial in United States (Cabozantinib, Nivolumab)
Recruiting
- Colorectal Adenocarcinoma
- +6 more
-
Aurora, Colorado
- +4 more
Nov 19, 2021
Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond
Completed
- Mucinous Adenocarcinoma of the Rectum
- +9 more
- intensity-modulated radiation therapy
- +4 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Jul 19, 2021
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Germany (Cetuximab, FOLFIRI)
Active, not recruiting
- Adenocarcinoma of the Colon
- Adenocarcinoma of the Rectum
- Cetuximab
- FOLFIRI
-
Bochum, Germany
- +3 more
Oct 14, 2021
Metastatic Adenocarcinoma of the Colon or Rectum, Malignant Solid Tumors Trial in Germany, United States (Anti-Macrophage
Completed
- Metastatic Adenocarcinoma of the Colon or Rectum
- Malignant Solid Tumors
- Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
-
Scottsdale, Arizona
- +4 more
May 3, 2021
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)
Not yet recruiting
- Rectal Adenocarcinoma
- +8 more
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Clinical, Histological and Prognostic Forms of Adenocarcinoma of
Active, not recruiting
- Anal Adenocarcinoma
-
Paris, France
- +1 more
Nov 7, 2022
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Rectal Cancer Trial in Madison (FOLFOX4, Cetuximab)
Terminated
- Rectal Cancer
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Dec 11, 2019